The use of drugs or specific bioactive food components with anti-inflammatory properties to reduce the inflammatory state associated with obesity, especially in the hypothalamus, may help to overcome leptin resistance. Here, LEP is linked to obesity due to melanocortin 4 receptor deficiency.